<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="t0001" orientation="portrait" position="float">
 <label>Table 1.</label>
 <caption>
  <p>Baseline characteristics of patients enrolled in the study</p>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col width="1*" align="left"/>
   <col width="1*" align="center"/>
   <col width="1*" align="center"/>
   <col width="1*" align="center"/>
  </colgroup>
  <thead>
   <tr>
    <th align="left">
     <bold>Variables</bold>
    </th>
    <th align="center">
     <bold>IPA</bold>
     <break/>
     <bold>(n = 50)</bold>
    </th>
    <th align="center">
     <bold>No IPA</bold>
     <break/>
     <bold>(n = 48)</bold>
    </th>
    <th align="center">
     <bold>P value</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">
     <bold>Age, no (%)</bold>
    </td>
    <td align="center"> </td>
    <td align="center"> </td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">≤50 years</td>
    <td align="center">9 (18.0)</td>
    <td align="center">13 (27.1)</td>
    <td align="center">0.34</td>
   </tr>
   <tr>
    <td align="left">&gt;50 years</td>
    <td align="center">41 (82.0)</td>
    <td align="center">35 (72.9)</td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">
     <bold>Gender, no (%)</bold>
    </td>
    <td align="center"> </td>
    <td align="center"> </td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">Female</td>
    <td align="center">23 (46.0)</td>
    <td align="center">21 (43.8)</td>
    <td align="center">0.84</td>
   </tr>
   <tr>
    <td align="left">Male</td>
    <td align="center">27 (54.0)</td>
    <td align="center">27 (56.2)</td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">
     <bold>Underlying disease, no (%)</bold>
    </td>
    <td align="center"> </td>
    <td align="center"> </td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">SOT*</td>
    <td align="center">12 (24.0)</td>
    <td align="center">20 (41.7)</td>
    <td align="center">0.22</td>
   </tr>
   <tr>
    <td align="left">Acute leukemia</td>
    <td align="center">9 (18.0)</td>
    <td align="center">10 (20.8)</td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">Allogeneic HSCT</td>
    <td align="center">9 (18.0)</td>
    <td align="center">6 (12.5)</td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">Chronic lymphoproliferative diseases</td>
    <td align="center">7 (14.0)</td>
    <td align="center">6 (12.5)</td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">Influenza A (H1N1)</td>
    <td align="center">6 (12.0)</td>
    <td align="center">0 (0.0)</td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">Chronic lung diseases</td>
    <td align="center">2 (4.0)</td>
    <td align="center">1 (2.1)</td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">Solid tumors</td>
    <td align="center">2 (4.0)</td>
    <td align="center">1 (2.1)</td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">Other</td>
    <td align="center">3 (6.0)</td>
    <td align="center">4 (8.3)</td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">
     <bold>Severe neutropenia, no (%)†</bold>
    </td>
    <td align="center">15 (30.0)</td>
    <td align="center">5 (10.4)</td>
    <td align="center">0.023</td>
   </tr>
   <tr>
    <td align="left">
     <bold>BAL cell counts, mean (range)‡</bold>
    </td>
    <td align="center"> </td>
    <td align="center"> </td>
    <td align="center"> </td>
   </tr>
   <tr>
    <td align="left">Neutrophils</td>
    <td align="center">5.5 (0.0–30.3)</td>
    <td align="center">4.5 (0.1–17.3)</td>
    <td align="center">0.30</td>
   </tr>
   <tr>
    <td align="left">Lymphocytes</td>
    <td align="center">4.2 (0–175.7)</td>
    <td align="center">1.8 (0.2–17.4)</td>
    <td align="center">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">
     <bold>GMI, mean (range)</bold>
    </td>
    <td align="center">5.1 (1.0–6.9)</td>
    <td align="center">0.11 (0.1–0.2)</td>
    <td align="center">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">
     <bold>Other pathogens detected in BAL, no (%)</bold>
     <break/>Virus
     <break/>Bacteria
     <break/>Fungi
    </td>
    <td align="center">
     <break/>25 (50.0)
     <break/>10 (20.0)
     <break/>8 (16.0)
    </td>
    <td align="center">
     <break/>16 (33.3)
     <break/>8 (16.7)
     <break/>5 (10.4)
    </td>
    <td align="center">
     <break/>0.92
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="tfn0001">
   <p>SOT, solid organ transplantation; HSCT, hematopoietic stem-cell transplantation; BAL, bronchoalveolar lavage; GMI, galactomannan index; P values were calculated by Fisher’s exact probability t-test for categorical variables, or by Student’s t-test or Mann–Whitney U test for continuous variables. *The study included 32 patients who received a SOT from lung (n = 26), kidney (n = 2), and liver (n = 2). Among those, 12 were diagnosed with IPA (lung, n = 8; kidney, n = 2; and liver, n = 2). †Severe neutropenia was defined as ≤0.5 × 10
    <sup>9</sup> cells/L. ‡Cell counts in BAL were expressed as the number ×10
    <sup>3</sup> cells/µL.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
